logo-poxel
HomeSite map

Site map

  • Home

  • About Poxel

    • Mission
    • Business model
    • Management Team
    • Board of Directors
    • History

  • Poxel's science

    • Scientific background
    • Drug targets
    • Market
    • Scientific advisory board

  • Product Pipeline

    • Pipeline
    • Imeglimin
    • GLP1 Receptor Agonist
    • AMPK Activator
    • FXR-Agonists
    • Glucokinase Activators
    • 11ß-HSD1 Inhibitors

  • News and Events

    • Flash News
    • Press releases
    • Congresses
    • Publications

  • Others

    • Contact Us
    • Site map
    • Legals

Recent news

> July 2010
Poxel Raises €16 million in a Series A Financing to Accelerate Pipeline Development

Read more...

> September 2009
Poxel earns €430,000 grant from public organizations for a cooperative project named NATHEB

Project co-financed by the European Union

Europe commits with the European Fund for Regional Development

Read more...
About Poxel | Poxel's science | Product pipeline | News and Events | Contact | Site map | Legal
xhtmlcss